Form 4: ACUREN Director James Lillie Reports Stock Transactions and Holdings

ACUREN Corp. Director James E. Lillie reported the settlement of restricted stock units into common stock and the grant of new restricted stock units, alongside his indirect beneficial ownership through Mariposa Acquisition IX, LLC.

Summary

• Director James E. Lillie acquired 10,000 shares of ACUREN Corp. Common Stock on July 30, 2025, through the settlement of restricted stock units.
• On July 30, 2025, 10,000 restricted stock units vested and were disposed of as they converted into common stock.
• Mr. Lillie was granted 9,017 new restricted stock units on July 31, 2025, which are scheduled to vest on July 31, 2026.
• Mr. Lillie indirectly beneficially owns approximately 1,746,169 shares of Common Stock and 92,500 shares of Common Stock issuable upon conversion of Series A Preferred Stock through his interest in Mariposa Acquisition IX, LLC.
• Mariposa Acquisition IX, LLC directly holds 18,877,500 shares of Common Stock and 1,000,000 shares of Series A Preferred Stock.

Sentiment

Score: 7

Explanation: The filing reflects routine insider transactions related to equity compensation and existing investment structures. The acquisition of shares through RSU settlement and the grant of new RSUs are generally positive for insider alignment, but the filing itself does not indicate significant new strategic developments or financial performance.

Positives

• Acquisition of 10,000 Common Stock shares through RSU settlement, increasing direct holdings.
• Grant of 9,017 new restricted stock units, indicating continued equity incentive and alignment with shareholder interests.

Future Outlook

The filing indicates future vesting of 9,017 restricted stock units on July 31, 2026, and the potential future conversion of Series A Preferred Stock held by Mariposa Acquisition IX, LLC into Common Stock by December 31, 2034, or earlier upon a change of control dividend date.

Industry Context

NA

Related Party Transactions

• James E. Lillie's indirect beneficial ownership of Common Stock and Series A Preferred Stock through Mariposa Acquisition IX, LLC, where he holds a limited liability company interest.

Stakeholder Impact

• Shareholders: The settlement of RSUs and grant of new ones represent routine equity compensation, potentially aligning director interests with shareholders. The indirect ownership structure through Mariposa IX is a significant existing holding.
• Employees: Not directly impacted by this specific filing.
• Customers: Not directly impacted by this specific filing.
• Suppliers: Not directly impacted by this specific filing.
• Creditors: Not directly impacted by this specific filing.

Next Steps

• Vesting of 9,017 restricted stock units on July 31, 2026.
• Potential conversion of Series A Preferred Stock held by Mariposa Acquisition IX, LLC into Common Stock.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions, specifically the vesting and settlement of restricted stock units and the grant of new units, along with existing indirect beneficial ownership. Such transactions are typical for directors receiving equity compensation and do not provide new information that would warrant a change in investment thesis. The filing does not contain any material financial or strategic updates that would significantly alter the company's outlook or valuation, thus a 'hold' recommendation is appropriate as it maintains current positions based on existing company fundamentals.

Keywords

ACUREN Corp, TIC, SEC Form 4, Beneficial Ownership, Restricted Stock Units, Common Stock, Series A Preferred Stock, Insider Trading, Director Holdings, Equity Compensation, Mariposa Acquisition IX